News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Bill Ackman sought Vincent Bollore's backing for his $64bn Universal Music bid; Bollore's ~32% stake can block the deal.
  • Wise reported a 24% rise in Q4 underlying income and 27% higher cross-border volumes, and confirmed a U.S. primary listing for May 11.
  • Hexagon will buy Baker Hughes' Waygate Technologies for about $1.45bn, with closing expected in H2 2026.
  • BOJ Governor Ueda warned rising Middle East tensions and higher oil prices threaten Japan's growth and inflation outlook.
  • Australia's S&P/ASX 200 fell 0.39% as gold, IT and industrials lagged, volatility rose and oil prices gained.
  • Paddington The Musical won seven Olivier Awards, including best new musical and best director.

Latest Articles

Xos Delivers Third Consecutive Quarter of Positive Operating and Free Cash Flow, Accelerates Platform Expansion Across Vehicles, Powertrains, and Energy Storage

Xos Delivers Third Consecutive Quarter of Positive Operating and Free Cash Flow, Accelerates Platform Expansion Across Vehicles, Powertrains, and Energy Storage

Xos, Inc. reported its fourth quarter and full-year 2025 financial results, achieving its third consecutive quarter of positive operating and free cash flow. The company expanded its platform with first production powertrains delivered to Blue Bird school buses and advanced its energy storage technology with significant gigawatt-hour charging miles…

ROC Access Face1 Wins “Best in Biometrics” at ISC West 2026 Security Industry Association New Products and Solutions Awards

ROC Access Face1 Wins “Best in Biometrics” at ISC West 2026 Security Industry Association New Products and Solutions Awards

Rank One Computing Corporation (ROC) announced that its ROC Access Face1 biometric reader has won the 'Best in Biometrics' award at the 2026 Security Industry Association New Products and Solutions Awards at ISC West. The product's innovative design and integration of biometric verification, video analytics, and intelligent access demonstrate ROC's…

Unity rallies after Q1 beat and move to exit ad businesses

Unity rallies after Q1 beat and move to exit ad businesses

Unity Software reported preliminary first-quarter results that exceeded its guidance across revenue and adjusted EBITDA, driven by growth in Unity Vector and Create. The company said it will retire the ironSource Ads Network and is pursuing a divestiture of its Supersonic game publishing unit. Shares rose sharply in after-hours trading following th…

Vroom Announces Fourth Quarter and Full Year 2025 Results

Vroom Announces Fourth Quarter and Full Year 2025 Results

Vroom, Inc. announced its Q4 and full-year 2025 financial results highlighting a $129.3 million improvement in net loss compared to 2024 and strengthened liquidity with $48.7 million total available. The company emerged from Chapter 11 in January 2025 with fresh start accounting impacting comparability. Despite improvements, adjusted net loss remai…

New Mexico Seeks Court-Ordered Product Changes at Meta After Jury Finds Liability

New Mexico Seeks Court-Ordered Product Changes at Meta After Jury Finds Liability

A New Mexico jury found Meta liable under state consumer protection laws and imposed a $375 million penalty for enabling child sexual exploitation on its platforms. The state is preparing a second, bench-phase of the trial in May that could lead a judge to require changes to how Facebook, Instagram and other Meta apps serve and verify underage user…

CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results

CapsoVision Reports Fourth Quarter and Full Year 2025 Financial Results

CapsoVision, Inc. reported a 13% increase in Q4 2025 revenue and 15% growth for the full year compared to 2024, driven by increased sales of its CapsoCam Plus capsule endoscopy products. The company advanced its AI-assisted imaging technology with a 510(k) FDA submission, developed new CMOS sensors under an agreement with Canon, and raised $14 mill…

Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO

Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO

Beyond Air, Inc. announced that CEO Steve Lisi has resigned and Robert Goodman, the current Chief Commercial Officer, has been appointed as CEO effective immediately. The change aims to accelerate market adoption and scale commercial operations of their LungFit PH medical device. Mr. Goodman brings extensive leadership experience in healthcare and …

Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update

Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update

Rani Therapeutics announced its Q4 and full-year 2025 financial results along with significant corporate developments. The company secured a collaboration and licensing agreement with Chugai Pharmaceutical valued up to $1.085 billion, successfully completed a $60.3 million private placement, and initiated a Phase 1 clinical trial for RT-114, an ora…

Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports Fourth Quarter and Full-Year Fiscal 2025 Results

Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports Fourth Quarter and Full-Year Fiscal 2025 Results

Oxford Industries, owner of brands including Tommy Bahama and Lilly Pulitzer, reported a challenging fiscal 2025 with a 3% decrease in annual net sales to $1.48 billion and a GAAP loss per share of $1.86, impacted by noncash impairment charges and increased tariffs. Despite pressures, the company initiated fiscal 2026 guidance anticipating improved…

CEA Industries Provides Update on Status of Renegotiation of Asset Management Agreement with 10X Capital

CEA Industries Provides Update on Status of Renegotiation of Asset Management Agreement with 10X Capital

CEA Industries provides an update on ongoing efforts to renegotiate its Asset Management Agreement (AMA) with 10X Capital Asset Management LLC. The current Board of Directors seeks to amend the AMA with more favorable terms including reduced management fees, shorter contract term, and adjusted liquidated damages. However, 10X Capital has been uncoo…

TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Fourth Quarter 2025 Financial Results on March 31, 2026

TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Fourth Quarter 2025 Financial Results on March 31, 2026

TOMI Environmental Solutions, a NASDAQ-listed global company specializing in disinfection and decontamination technologies, announced it will release its fourth quarter 2025 financial results after market close on March 31, 2026, accompanied by a conference call. The company focuses on providing advanced environmental disinfection solutions utilizi…

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Iridex Reports Fourth Quarter and Full Year 2025 Financial Results

Iridex Corporation reported Q4 2025 revenues of $14.7 million, up 16% year-over-year, and full-year 2025 revenues of $52.7 million, an 8% increase from 2024. The company achieved positive adjusted EBITDA for the first time recently, driven by growth in glaucoma and retina product sales and reduced operating expenses. Despite global challenges, incl…

Datacentrex Announces Proposed Public Offering

Datacentrex Announces Proposed Public Offering

Datacentrex, Inc., a digital infrastructure firm specializing in Scrypt-based proof-of-work compute assets, has announced a proposed public offering of its common stock and pre-funded warrants. The net proceeds from this offering are intended to support working capital and general corporate needs. The offering is subject to market conditions and re…

INNOVATE Corp. Announces Fourth Quarter and Full Year 2025 Results

INNOVATE Corp. Announces Fourth Quarter and Full Year 2025 Results

INNOVATE Corp. announced its Q4 and full-year 2025 results featuring a 12.5% revenue increase driven mainly by its Infrastructure segment. The company improved net loss compared to the prior year quarter, boosted backlog to $1.8 billion, and made strides in Life Sciences with FDA approval and a major China system commitment. Despite softness in Spe…

IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results

IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results

Insight Molecular Diagnostics Inc. (Nasdaq: IMDX) announced the submission of its GraftAssureDx transplant rejection test for FDA regulatory review, marking a milestone after 12 years of development. The company reported Q4 2025 revenues of $1.1 million and a full year of $4.1 million, driven by lab services, while gearing up for commercial launch …

VirTra Reports Fourth Quarter and Full Year 2025 Financial Results

VirTra Reports Fourth Quarter and Full Year 2025 Financial Results

VirTra, Inc., a Nasdaq-listed provider of use-of-force and firearms training simulators, reported a 15% revenue decline to $22.4 million for 2025, impacted by an atypical federal funding disruption delaying customer procurement and deliveries. Despite revenue pressures, bookings increased to $26.7 million, and backlog grew to $25.6 million. The com…

Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update

Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update

Spero Therapeutics announced positive financial results for the fourth quarter and full year of 2025, highlighted by a net income turnaround and increased revenues driven by collaborations with GSK and Pfizer. In December 2025, Spero's licensing partner, GSK, resubmitted the New Drug Application for tebipenem HBr, an oral carbapenem antibiotic for …

LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

LB Pharmaceuticals reported positive results from Phase 2 trials of LB-102 in schizophrenia, initiated pivotal Phase 3 and additional Phase 2 trials for bipolar depression and major depressive disorder, and announced a $100 million private placement. The company has a strong cash position of $295.2 million as of December 31, 2025, providing a runwa…

Alpine Income Property Trust Announces First Quarter 2026 Earnings Release and Conference Call Information

Alpine Income Property Trust Announces First Quarter 2026 Earnings Release and Conference Call Information

Alpine Income Property Trust, Inc., a publicly traded REIT focusing on single tenant net leased commercial properties and commercial loan investments, announced it will release its Q1 2026 financial results after market close on April 23, 2026, followed by a conference call on April 24, 2026. The company aims to provide updates on its portfolio and…